Sam Brusco, Associate Editor06.05.24
restor3d has closed a $55 million Series A funding round, led by Summer Value Partners and existing investors. The company also gained a further $15 million in debt financing led by Trinity Capital.
The company said the significant investment will accelerate growth and innovation in several key areas.
restor3d said it will introduce new patient-specific implants for total ankle and shoulder replacements. The 3D-printed solutions aim to fit patients’ unique anatomy and pathology. A porous, press-fit knee enabled by 3D printing the tibial and femoral components is one such example.
The company will continue to invest in novel 3D printing tech and expand its in-house “powder to sterile product” environment. The investments aim to shorten personalized implant delivery time and reduce production costs.
Continued investments will be made in software and design automation. This will speed case intake and design processes, lower digital design times, and improve service levels.
The new funding will also enable expansion of restor3d’s educational initiatives. Surgeons and the company’s sales team will be provided with training on the latest tech and surgical techniques in orthopedic and reconstructive surgery.
“This fundraising round is a testament to the confidence our investors have in restor3d’s vision and potential," said CEO Kurt Jacobus. “With this capital, we can accelerate our efforts to transform orthopedic care through 3D printed personalized implants. We are eager to maximize our impact on patient outcomes and continue to advance of orthopedic care. We are grateful for the support from our investors and look forward to a future of continued growth and success.”
Earlier this year, restor3d closed its acquisition deal for Conformis, adding to its patient-specific implant portfolio.
The company said the significant investment will accelerate growth and innovation in several key areas.
restor3d said it will introduce new patient-specific implants for total ankle and shoulder replacements. The 3D-printed solutions aim to fit patients’ unique anatomy and pathology. A porous, press-fit knee enabled by 3D printing the tibial and femoral components is one such example.
The company will continue to invest in novel 3D printing tech and expand its in-house “powder to sterile product” environment. The investments aim to shorten personalized implant delivery time and reduce production costs.
Continued investments will be made in software and design automation. This will speed case intake and design processes, lower digital design times, and improve service levels.
The new funding will also enable expansion of restor3d’s educational initiatives. Surgeons and the company’s sales team will be provided with training on the latest tech and surgical techniques in orthopedic and reconstructive surgery.
“This fundraising round is a testament to the confidence our investors have in restor3d’s vision and potential," said CEO Kurt Jacobus. “With this capital, we can accelerate our efforts to transform orthopedic care through 3D printed personalized implants. We are eager to maximize our impact on patient outcomes and continue to advance of orthopedic care. We are grateful for the support from our investors and look forward to a future of continued growth and success.”
Earlier this year, restor3d closed its acquisition deal for Conformis, adding to its patient-specific implant portfolio.